Research Bio
Dr. Janelsins' laboratory focuses on : 1) understanding clinical, psychological, and biological mechanisms of cognitive difficulties in cancer patients 2) investigating interventions to alleviate cognitive difficulties in cancer patients, and 3) translational models of cognitive difficulties in cancer.
Dr. Janelsins' area of expertise is in psychoneuroimmunology, immunology, neuroscience, and cognitive science. In addition to a focus on cognition and cancer, her lab is broadly interested in many aspects of research related to quality of life improvement and side effect management in cancer.
| Markey Cancer Center and NCI International Conference on the Side Effects of Cancer Research Abstract Award |
2011 |
| NCI Clinical Research Loan Repayment Program Award |
2011 - Present |
| ASPO New Investigator Award |
2011 |
| Distinguished Fellow, NIH Institute on Design & Conduct of Randomized Controlled Trials Involving Behavioral Interventions | OBSSR |
2010 |
| Highest Ranked Abstract Award for the Annual Meeting of ASPO | American Society of Preventive Oncology |
2010 |
| Research Abstract Award | Society of Behavioral Medicine |
2009 |
| First Prize Poster Award | American Society for Preventive Oncology |
2009 |
| First Prize Poster Award in Cancer Control/Epidemiology | James P. Wilmot Cancer Center |
2008 |
| NCI Cancer Control Fellowship Award |
2008 - 2012 |
| Outstanding Abstract Award | Keystone: Alzheimer's Disease Meeting |
2006 |
| Individual National Research Service Award (NRSA) | NINDS |
2005 - 2008 |
| Scholarship | Pathogenesis of Neuroimmunologic Diseases | Marine Biological Laboratory |
2005 |
| Melville Hare Award for Excellence in Teaching | University of Rochester |
2004 |
| Summer Scholars Fellowship/Grant | Howard Hughes, Ursinus College |
2001 |
2013 May 3
Kesler S, Hosseini SM, Heckler C, Janelsins M, Palesh O, Mustian K, Morrow G. "Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors." Clinical breast cancer. 2013 May 3; Epub 2013 May 03. |
2013 Mar
Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, Dhabhar FS. "Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors." Brain, behavior, and immunity. 2013 Mar 0; 30 Suppl:S109-16. Epub 2012 Jun 12. |
2012 Oct
Palesh OG, Mustian KM, Peppone LJ, Janelsins M, Sprod LK, Kesler S, Innominato PF, Roth T, Manber R, Heckler C, Fiscella K, Morrow GR. "Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program." Sleep medicine. 2012 Oct 0; 13(9):1184-90. Epub 2012 Aug 02. |
2012 Aug
Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, Skinner KA. "The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels." Annals of surgical oncology. 2012 Aug 0; 19(8):2590-9. Epub 2012 Mar 24. |
2012 Jun 1
Kirshner JJ, Heckler CE, Janelsins MC, Dakhil SR, Hopkins JO, Coles C, Morrow GR. "Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2012 Jun 1; 30(16):1974-9. Epub 2012 Apr 16. |
